Protein from red blood cells and process for isolating it

Claim 2

A process for isolating a protein characterized by (a) a protein content of 99%±1% and a content of carbohydrates of 0.9%±0.5%, and a compositional analysis including the following major amino-acid and carbohydrate fractions: ______________________________________ Amino Acids Mol % Variation Coefficient % ______________________________________ Aspartic acid 11.39 1.21 Glutamic acid 8.44 4.35 Glycine 9.13 2.22 Alanine 7.35 1.68 Valine 8.96 1.36 Leucine 8.79 3.83 ______________________________________ ______________________________________ Carbohydrates % by weight ______________________________________ Hexoses (Gal/Man 1:1) 0.9 ± 0.2 Acetylhexoseamine 0.3 ± 0.1; ______________________________________ (b) a sedimentation coefficient S 20w C ═O of 6.88±0.5S; (c) a molecular weight of 160,000±15,000; (d) an iso-electric point of 5.5±0.2; (e) an electrophoretic mobility in the range of the β 1 -globulins of human serum; and (f) a specific immunological reaction with an antibody specifically directed against the protein, which process comprises extracting the protein from red blood cells or from an aqueous solution having an electrical conductivity of from 1 to 10 μS/cm and containing the protein; adsorbing said protein from the aqueous solution on an anion exchanger at a pH value of between 6.5 and 7.5, thereby separating the protein from the supernatant of said aqueous solution; treating the anion exchanger and adsorbed protein with a series of salt solutions of varying concentration to elute that which was adsorbed on the exchanger in various fractions; identifying each fraction containing the protein; concentrating the protein by ultra-filtration; fractionating the concentrate by gel-filtration and elution; identifying each resultant fraction containing the protein, and concentrating the protein by ultra-filtration.

Claim 3

A process as defined in claim 1, wherein the red blood cells are lyzed by introducing them into a hypotonic medium and the sedimentary components of the red blood cells are removed to yield said aqueous solution containing the protein.

Claim 4

A process as defined in claim 1, wherein the protein is extracted from red blood cells in a blood-rich organ to form an aqueous solution containing the protein.

Claim 5

The process of claim 1, wherein a proteinase inhibitor is added to the aqueous solution containing the protein.

Claim 6

An isolated, concentrated, protein obtained by fractionating an extract of blood or of a blood-rich organ, said protein having (a) a protein content of 99%±1% and a content of carbohydrates of 0.9%±0.5%, and a compositional analysis as follows: ______________________________________ Amino Acids Mol % Variation Coefficient % ______________________________________ Lysine 6.68 2.67 Histidine 1.61 5.08 Arginine 5.05 3.97 Aspartic acid 11.39 1.21 Threonine 5.05 2.23 Serine 4.98 4.12 Glutamic acid 8.44 4.35 Proline 5.66 6.95 Glycine 9.13 2.22 Alanine 7.35 1.68 1/2 Cystine 1.65 2.04 Valine 8.96 1.36 Methionine 0.32 28.87 Isoleucine 4.84 1.17 Leucine 8.79 3.83 Tyrosine 3.34 4.24 Phenylalanine 5.92 3.81 Tryptophan 1.01 10.30 ______________________________________ ______________________________________ Carbohydrates % by weight ______________________________________ Hexoses (Gal/Man 1:1) 0.9 ± 0.2 Acetylhexoseamine 0.3 ± 0.1 Acetyl-neuraminic acid 0 Fucose 0 ______________________________________ (b) a sedimentation coefficient S 20w C ═O of 6.88±0.5S; (c) a molecular weight of 160,000±15,000; (d) an iso-electric point of 5.5±0.2; (e) an electrophoretic mobility in the range of the β 1 -globulins of human serum; and (f) a specific immunological reaction with an antibody specifically directed against the protein.

Claim 7

An isolated, concentrated, protein obtained by fractionating an extract of blood or of a blood-rich organ, said protein having (a) a protein content of 99%±1% and a content of carbohydrates of 0.9%±0.5%, and a compositional analysis as follows: ______________________________________ Amino Acids Mol % Variation Coefficient % ______________________________________ Lysine 6.68 2.67 Histidine 1.61 5.08 Arginine 5.05 3.97 Aspartic acid 11.39 1.21 Threonine 5.05 2.23 Serine 4.98 4.12 Glutamic acid 8.44 4.35 Proline 5.66 6.95 Glycine 9.13 2.22 Alanine 7.35 1.68 1/2 Cystine 1.65 2.04 Valine 8.96 1.36 Methionine 0.32 28.87 Isoleucine 4.84 1.17 Leucine 8.79 3.83 Tyrosine 3.34 4.24 Phenylalanine 5.92 3.81 Tryptophan 1.01 10.30 ______________________________________ ______________________________________ Carbohydrates % by weight ______________________________________ Hexoses (Gal/Man 1:1) 0.9 ± 0.2 Acetylhexoseamine 0.3 ± 0.1 Acetyl-neuraminic acid 0 Fucose 0 ______________________________________ (b) a sedimentation coefficient S 20w C ═O of 6.88±0.5S; (c) a molecular weight of 160,000±15,000; (d) an iso-electric point of 5.5±0.2; (e) an electrophoretic mobility in the range of the β 1 -globulins of human serum; and (f) a specific immunological reaction with an antibody specifically directed against the protein.

Claim 8

A process for the production of an antiserum to the protein defined in claim 5, which comprises immunizing a host vertebrate animal with said protein, withdrawing blood from the animal and separating the serum which contains antibodies to the protein from the blood.

Claim 9

The process as defined in claim 6, which further comprises isolating the gamma-globulin fraction, which contains said antibodies, from the serumm.

Claim 10

The antiserum which is the product of the process defined in claim 6 or 7.